Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
54.8 USD | +5.61% | +13.62% | +16.05% |
Financials (USD)
Sales 2024 * | 1.46B | Sales 2025 * | 1.55B | Capitalization | 1.88B |
---|---|---|---|---|---|
Net income 2024 * | 133M | Net income 2025 * | 185M | EV / Sales 2024 * | 2.14 x |
Net Debt 2024 * | 1.26B | Net Debt 2025 * | 1.02B | EV / Sales 2025 * | 1.87 x |
P/E ratio 2024 * |
14.1
x | P/E ratio 2025 * |
10.5
x | Employees | 1,700 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 82.73% |
Latest transcript on Ingevity Corporation
1 day | +5.61% | ||
1 week | +13.62% | ||
Current month | +7.16% | ||
1 month | +15.64% | ||
3 months | +23.62% | ||
6 months | +39.62% | ||
Current year | +16.05% |
Managers | Title | Age | Since |
---|---|---|---|
John Fortson
CEO | Chief Executive Officer | 56 | 15-10-11 |
Mary Hall
DFI | Director of Finance/CFO | 67 | 21-04-18 |
John Nypaver
IRC | Investor Relations Contact | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Karen Narwold
BRD | Director/Board Member | 64 | 19-02-19 |
Jean Blackwell
CHM | Chairman | 69 | 16-04-30 |
Frederick Lynch
BRD | Director/Board Member | 59 | 16-04-30 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.13% | 45 M€ | +0.69% | ||
0.11% | 509 M€ | -.--% |
Date | Price | Change | Volume |
---|---|---|---|
24-05-02 | 54.8 | +5.61% | 642,072 |
24-05-01 | 51.89 | +1.47% | 430,767 |
24-04-30 | 51.14 | +0.37% | 215,608 |
24-04-29 | 50.95 | +5.03% | 279,840 |
24-04-26 | 48.51 | +1.34% | 146,152 |
Delayed Quote Nyse, May 02, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+16.05% | 1.88B | |
+1.22% | 76.93B | |
-0.28% | 46.86B | |
+1.07% | 32.74B | |
+10.05% | 18.58B | |
-9.81% | 11.54B | |
+6.79% | 11.14B | |
-6.33% | 9.8B | |
+5.97% | 9.72B | |
+7.57% | 9.3B |
- Stock Market
- Equities
- NGVT Stock